Article info
PDFRheumatoid arthritis
Review
Era of biosimilars in rheumatology: reshaping the healthcare environment
- Correspondence to Dr Josef S Smolen; josef.smolen.ard{at}meduniwien.ac.at
Citation
Era of biosimilars in rheumatology: reshaping the healthcare environment
Publication history
- Received January 8, 2019
- Revision received March 27, 2019
- Accepted April 15, 2019
- First published May 21, 2019.
Online issue publication
May 21, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.